News

Dune Medical Devices has reached another milestone in their MarginProbe® Post Approval Study (PAS) as Johns Hopkins Hospital and Moffitt Cancer Center complete their patient enrollments for the trial.

Dune Medical Devices was thrilled to host Congresswoman Lucy McBath in a recent visit to their Alpharetta office. McBath is a member of the United States House of Representatives from Georgia's 6th congressional district. Since joining Congress in January of this year, she has shown support for multiple bills seeking to lower costs of healthcare for patients and help advance medical innovation.

As part of their whole-person care strategy, Dr. Wilson’s practice uses a new tool, known as MarginProbe, to ensure that a safe margin of tissue is removed around a cancerous tumor as that tumor is removed during surgery.

Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radio-frequency (RF) spectroscopy technology.

Lori Chmura and Tom Melba attended the 24th Annual Multidisciplinary Symposium on Breast Disease to exhibit MarginProbe, the only FDA approved intraoperative tool for margin assessment. Here are some of their favorite moments from the symposium.

Global breast surgeon thought leaders from the United States, Germany, Israel, the UK and Japan came together during an international investigator reception at the San Antonio Breast Cancer Symposium, hosted by Dune Medical.

After being awarded Medtech Woman of the Year for 2018 by MW@S, Lori joined Jason Rupp on the webinar to discuss her work with Dune Medical Devices, the challenges she faced as a woman in the medtech industry, and more.

Dune Medical CEO Lori Chmura and Chairman of the Board of Directors Amos Goren started the year off by attending the 37th Annual J.P. Morgan Healthcare Conference

With the year coming to an end we put together an overview of the many developments in breast cancer research and treatment from 2018.

The American Society of Breast Surgeons (ASBrS) united thought leaders, payment and reimbursement experts, and Industry Relations Council members to develop a strategic approach to prepare its physician members to lead enhancements in breast cancer surgery, therapeutics and technology for the future.

Events

Event Information: